Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

MediciNova Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

MediciNova Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 May 2015 Reuters Investment Profile 12 $20.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

25 May 2015 Pechala's Reports 85 $1,000.00

Thomson Reuters Stock Report - MEDICINOVA INC (4875-JA)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

22 May 2015 Thomson Reuters Stock Report 10 $25.00

Value Graph: MEDICINOVA -- MNOV

22 May 2015 Ford Investor Services, Inc. 1 $12.00

ValuEngine Industry Report for Medical-biomed/genetics(MNOV)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

21 May 2015 ValuEngine, Inc. 10 $49.00

MediciNova, Inc. (MNOV) - Financial and Strategic SWOT Analysis Review

MediciNova, Inc. (MNOV) - Financial and Strategic SWOT Analysis Review Summary MediciNova, Inc. (MediciNova) is a biopharmace...

19 May 2015 GlobalData 39 $125.00

"The Economy Matters" Report for MNOV: the economy's impact on MNOV's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

19 May 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for MNOV

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

18 May 2015 ValuEngine, Inc. 10 $25.00

MEDICINOVA - PROGRESS IN MS AND ALS

MediciNova has five Phase II clinical trials ongoing in progressive multiple sclerosis (MS), Lou Gehrig’s Disease (ALS) and a...

01 May 2015 Edison Investment Research 2 $10.00